Search
News & Events
Netball star on the ballWest Coast Fever netball player Verity Charles is proof that living with T1D doesn't mean your sporting dream has to take a backseat to your condition
News & Events
Sleepover safetyA big part of being a kid is having sleepovers at friend’s places but often children with diabetes miss out.
News & Events
Q&A with NiruMeet Nirubasini, or Niru as she is affectionately known among the Children’s Diabetes Centre team.
News & Events
Family’s fundraising efforts a hole-in-oneWhen Meghan Bunter’s daughter was first diagnosed with diabetes, she felt overwhelmed not only with Ella’s diagnosis but also the flood of donation requests.
News & Events
Virtual reality diabetesWhen Josh Wulf’s son was diagnosed with Type 1 Diabetes, little did he know that one day he would be helping other T1D families manage the condition.
News & Events
Unwanted devices?The PMH Diabetes and Endocrinology clinic is seeking donations of old Apple and android devices to pass on to families for CGM.
News & Events
Setting smart phone rulesMobile phones are an important part of diabetes management but its also important to set some family rules for your child's technology use.
Research
Plastics in human diets: development and evaluation of the 24-h Dietary Recall — Plastic Exposure and the Dietary Plastics ScoreHumans are commonly exposed to plastic through their dietary intake and food consumption patterns. Plastic-associated chemicals (PAC), such as bisphenols and phthalates, are recognized as endocrine-disrupting and are associated with increased risk of cardiovascular disease and metabolic syndrome. However, accurate methods to assess dietary exposure to plastic products and PAC are inadequate, limiting interrogation of health impacts.
Research
Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global PerspectiveGlobally, nearly 9 million people are living with type 1 diabetes (T1D). Although the incidence of T1D is not affected by socioeconomic status, the development of complications and limited access to modern therapy is overrepresented in vulnerable populations. Diabetes technology, specifically continuous glucose monitoring and automated insulin delivery systems, are considered the gold standard for management of T1D, yet access to these technologies varies widely across countries and regions, and varies widely even within high-income countries.
Research
Real-world glycaemic outcomes in children and young people on advanced hybrid closed-loop therapy: A population-based study in Western AustraliaTo evaluate real-world glycaemic outcomes in children with type 1 diabetes commencing advanced hybrid closed loop therapy and to explore these outcomes based on the cohort's clinical and socioeconomic characteristics.